about
Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid LeukemiaBrd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis.Regulation of neuronal survival by DNA methyltransferases.Chromatin modifying gene mutations in follicular lymphoma.Leveraging Genomics for Head and Neck Cancer Treatment.A de novo KMT2D mutation in a girl with Kabuki syndrome associated with endocrine symptoms: a case report.Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner Syndrome
P2860
Q42694670-2B156D44-5CDF-4614-B3AC-894D60088436Q47134917-6DC66AF4-C262-4B81-9DD1-57744CF073D1Q47162103-A0B8F65E-D599-49FF-B942-63A0210FBD36Q47828228-F66E824E-8A1A-4232-A393-D23FFFEED847Q50116331-BF518E0A-1843-4E06-880A-5D309037BAE9Q55332038-210158C6-6214-4F18-AC00-D79F3C5EE252Q58713450-AA06F0C5-A880-43FE-9FCA-A75265AAD143
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Histone H3 lysine 4 methyltransferase KMT2D.
@en
Histone H3 lysine 4 methyltransferase KMT2D.
@nl
type
label
Histone H3 lysine 4 methyltransferase KMT2D.
@en
Histone H3 lysine 4 methyltransferase KMT2D.
@nl
prefLabel
Histone H3 lysine 4 methyltransferase KMT2D.
@en
Histone H3 lysine 4 methyltransferase KMT2D.
@nl
P2860
P1433
P1476
Histone H3 lysine 4 methyltransferase KMT2D.
@en
P2093
Eugene Froimchuk
P2860
P304
P356
10.1016/J.GENE.2017.06.056
P407
P577
2017-06-29T00:00:00Z